AMGN vs GPCR · P/E 24, rev $10.05B vs $1.09B cap
Amgen Inc (AMGN) versus Structure Therapeutics Inc. American Depositary Shares (GPCR) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Structure Therapeutics Inc. American Depositary Shares (GPCR) is a biotechnology company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
GPCR does not have a complete income-statement cache yet.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. GPCR currently screens at market cap $1.09B.
Not investment advice. Open the AMGN and GPCR stock pages for the full models.
Not investment advice.